Cargando…
Preliminary results on anal cancer by applying intensity modulated radiotherapy and synchronous capecitabine chemotherapy simultaneously
BACKGROUND: Anal cancer is a rare clinical disease with the incidence rate of 1–2/10 million. The present study aims to assess the feasibility, safety and short-term outcome of the simultaneous integrated boost intensity-modulated radiotherapy (SIB-IMRT) schedule with oral capecitabine in patients w...
Autores principales: | Xu, Wei-Dong, Jiang, Hua-Yong, Gao, Jun-Mao, Du, Jun-Feng, Chen, Gang, Zhang, Fu-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798329/ https://www.ncbi.nlm.nih.gov/pubmed/35117802 http://dx.doi.org/10.21037/tcr-19-2843 |
Ejemplares similares
-
Intensity-modulated radiotherapy for synchronous cancer of the anal canal and cervix
por: Kawamoto, Terufumi, et al.
Publicado: (2018) -
Capecitabine/Mitomycin versus 5-Fluorouracil/Mitomycin in Combination with Simultaneous Integrated Boost Intensity-Modulated Radiation Therapy for Anal Cancer
por: Mineur, Laurent, et al.
Publicado: (2023) -
Dosimetric advantages and clinical outcomes of simultaneous integrated boost intensity-modulated radiotherapy for anal squamous cell carcinoma
por: Sakanaka, Katsuyuki, et al.
Publicado: (2017) -
Efficacy and Side Effects of Combined Capecitabine Plus Intensity Modulated Radiotherapy as an Effective Adjuvant Therapy for Gastric Cancers
por: Fu, Jie, et al.
Publicado: (2020) -
Intensity-modulated radiotherapy with simultaneous modulated accelerated boost technique and chemotherapy in patients with nasopharyngeal carcinoma
por: Fareed, Muhammad M, et al.
Publicado: (2013)